Deep Genomics
2015
FOUNDED
PRIVATE
STATUS
31-40
EMPLOYEES
Series A
LATEST DEAL TYPE
$13M
LATEST DEAL AMOUNT
8
INVESTORS
Description
Developer of an integrated genetic computational system designed to interpret genetic variation. The company's integrated genetic computational system alters crucial cellular processes, including transcription, splicing, polyadenylation and translation, leading to effective therapies, enabling researchers to classify, prioritize, interpret and link genetic variants, whether natural or therapeutic.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
- MaRS Centre, Heritage Building
- Suite 320
- Toronto, Ontario M5G 1L7
- Canada
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Deep Genomics’s full profile, request a free trial.
Deep Genomics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 14-Aug-2017 | $13M | 000.00 | Completed | Startup | |
| 2. Early Stage VC | 18-Nov-2015 | 00.00 | 00.00 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Deep Genomics Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inscripta | Venture Capital-Backed | Boulder, CO | 00000 | 00000000000 | 00000 | |
| 000000000 00000000 | Venture Capital-Backed | San Diego, CA | 0 | 000.00 | 00000000000 | 000.00 |
| 000 000000 | Venture Capital-Backed | Paris, France | 000.00 | 00000000000 | 000.00 | |
| 0000000 0000000000 | Venture Capital-Backed | New York, NY | 0 | 00000 | 0000000000 | 00000 |
| 00000 00000000 | Private Equity-Backed | Aliso Viejo, CA | 000 | 00000 | 000000&0 | 00000 |
Deep Genomics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Toronto Innovation Acceleration Partners | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| 11.2 Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Bloomberg Beta | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| The UTEST Program | Accelerator/Incubator | 000 0000 | 000000 0 |
Deep Genomics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Brendan Frey Ph.D | Co-Founder, Chief Executive Officer & President |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »